aldesleukin [clinicaltrials_resource:add484da9c419230b3615dce9499b1c7]
Interleukin-2 Plus Interferon Alfa in Treating Adults With Metastatic Cancer [clinicaltrials:NCT00002504]Indomethacin Plus Biological Therapy in Treating Patients With Advanced Melanoma [clinicaltrials:NCT00002535]Cytotoxic T Cells and Interleukin-2 in Treating Adult Patients With Recurrent Brain Tumors [clinicaltrials:NCT00002572]Lymphocyte Therapy in Treating Patients With Kidney Cancer [clinicaltrials:NCT00002589]Biological Therapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Advanced Breast Cancer [clinicaltrials:NCT00002616]Biological Therapy in Treating Patients With Prostate Cancer [clinicaltrials:NCT00002637]Combination Chemotherapy, Interferon Alfa, and Interleukin-2 in Treating Patients With Metastatic Melanoma [clinicaltrials:NCT00002669]Monoclonal Antibody Plus Interleukin-2 in Treating Patients With Leukemia or Lymphoma [clinicaltrials:NCT00002681]Interleukin-2 in Treating Patients With Mycosis Fungoides [clinicaltrials:NCT00002687]Surgery and Radiation Therapy With or Without Interleukin-2 in Treating Patients With Cancer of the Mouth or Oropharynx [clinicaltrials:NCT00002702]Biological Therapy in Treating Patients With Metastatic Cancer [clinicaltrials:NCT00002733]Interleukin-2 in Treating Patients With Myelodysplastic Syndrome [clinicaltrials:NCT00002746]Biological Therapy in Treating Women With Metastatic Breast Cancer [clinicaltrials:NCT00002780]Biological Therapy in Treating Patients With Metastatic Melanoma [clinicaltrials:NCT00002786]Interleukin-2 in Treating Patients With Metastatic Melanoma [clinicaltrials:NCT00002845]Interleukin-2 in Treating Patients With Metastatic or Recurrent Kidney Cancer [clinicaltrials:NCT00002846]Interferon Alfa and Interleukin-2 in Treating Patients With Metastatic Kidney Cancer [clinicaltrials:NCT00002847]Inhaled Interleukin-2 in Treating Patients With Metastatic or Unresectable Cancer [clinicaltrials:NCT00003009]Combination Chemotherapy With or Without Interleukin-2 and Interferon Alfa in Treating Patients With Metastatic Melanoma [clinicaltrials:NCT00003027]Biological Therapy in Treating Patients With Primary or Advanced Glioma [clinicaltrials:NCT00003067]Biological Therapy in Previously Treated Patients With Non-small Cell Lung Cancer [clinicaltrials:NCT00003090]High-Dose Interferon Alfa and Interleukin-2 in Treating Patients With Metastatic Kidney Cancer or Melanoma [clinicaltrials:NCT00003091]Vaccine Therapy, Interleukin-2, and Sargramostim in Treating Patients With Advanced Tumors [clinicaltrials:NCT00003125]Interleukin-2 in Treating Patients With Stage III or Stage IV Kidney Cancer [clinicaltrials:NCT00003126]Interleukin-2 in Treating Patients With Relapsed or Refractory Acute Myelogenous Leukemia [clinicaltrials:NCT00003148]Interleukin-2, Vinblastine, and GM-CSF in Treating Patients With Metastatic Kidney Cancer [clinicaltrials:NCT00003181]Vaccine Therapy in Treating Patients With Metastatic Melanoma Who Are Undergoing Surgery for Lymph Node and Tumor Removal [clinicaltrials:NCT00003229]Combination Chemotherapy Plus Infusion of White Blood Cells in Treating Patients With Hematologic Cancer [clinicaltrials:NCT00003243]Rituximab Plus Interleukin-2 in Treating Patients With Lymphoma [clinicaltrials:NCT00003356]Biological Therapy Following Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Cancer [clinicaltrials:NCT00003408]Graft-Versus-Host Disease in Treating Patients With Recurrent or Refractory Lymphoma or Hodgkin's Disease [clinicaltrials:NCT00003414]Vaccine Therapy With High-Dose Interleukin-2 in Treating Patients With Metastatic Melanoma [clinicaltrials:NCT00003568]Biological Therapy Plus Chemotherapy in Treating Patients With Metastatic or Recurrent Kidney Cancer [clinicaltrials:NCT00003585]Interleukin-2 in Treating Patients With Stage III or Stage IV Kidney Cancer That Has Been Removed With Surgery [clinicaltrials:NCT00003604]Combination Chemotherapy and Biological Therapy In Treating Patients With Kidney Cancer That Is Metastatic or Cannot Be Removed Surgically [clinicaltrials:NCT00003664]Interleukin-2 in Treating Children With Stage IV Neuroblastoma Who Have Received Induction Therapy and Peripheral Stem Cell Transplantation [clinicaltrials:NCT00003743]Interleukin-2 Following Bone Marrow Transplantation in Treating Patients With Hematologic Cancer [clinicaltrials:NCT00003962]Interleukin-2 Plus Histamine Dihydrochloride in Treating Patients With Acute Myeloid Leukemia [clinicaltrials:NCT00003991]Bryostatin 1 and Interleukin-2 in Treating Patients With Refractory Solid Tumors or Lymphoma [clinicaltrials:NCT00003993]Biological Therapy Following Surgery in Treating Patients With Stage III or Stage IV Melanoma [clinicaltrials:NCT00004022]
intervention [clinicaltrials_vocabulary:intervention]
aldesleukin [clinicaltrials_resource:add484da9c419230b3615dce9499b1c7]
Bio2RDF identifier
add484da9c419230b3615dce9499b1c7
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:add484da9c419230b3615dce9499b1c7
intervention name [clinicaltrials_vocabulary:intervention-name]
aldesleukin
identifier
clinicaltrials_resource:add484da9c419230b3615dce9499b1c7
title
aldesleukin
@en
type
label
aldesleukin [clinicaltrials_resource:add484da9c419230b3615dce9499b1c7]
@en